Department of Bioinformatics, Science Block, Alagappa University, Karaikudi - 630 004, Tamil Nadu,India.
Department of Biotechnology, Indian Institute of Technology Madras, Room No. BT 306, Chennai-600 036, Tamil Nadu, India.
Comb Chem High Throughput Screen. 2022;25(4):660-676. doi: 10.2174/1386207324666210308110646.
This study aims to develop and establish a computational model that can identify potent molecules for p21-activating kinase 1 (PAK1) Background: PAK1 is a well-established drug target that has been explored for various therapeutic interventions. Control of this protein requires an indispensable inhibitor to curb the structural changes and subsequent activation of signalling effectors responsible for the progression of diseases, such as cancer, inflammatory, viral, and neurological disorders.
The study aims to establish a computational model that could identify active molecules which will further provide a platform for developing potential PAK1 inhibitors.
A congeneric series of 27 compounds were considered for this study, with Ki (nm) covering a minimum of 3 log range. The compounds were developed based on a previously reported Group-I PAK inhibitor, namely G-5555. The 27 compounds were subjected to the SP and XP mode of docking to understand the binding mode, its conformation and interaction patterns. To understand the relevance of biological activity from computational approaches, the compounds were scored against generated water maps to obtain WM/MM ΔG binding energy. Moreover, molecular dynamics analysis was performed for the highly active compound to understand the conformational variability and stability of the complex. We then evaluated the predictable binding pose obtained from the docking studies.
From the SP and XP modes of docking, the common interaction pattern with the amino acid residues Arg299 (cation-π), Glu345 (Aromatic hydrogen bond), hinge region Leu347, salt bridges Asp393 and Asp407 was observed, among the congeneric compounds. The interaction pattern was compared with the co-crystal inhibitor FRAX597 of the PAK1 crystal structure (PDB id: 4EQC). The correlation with different docking parameters in the SP and XP modes was insignificant and thereby revealed that the SP and XP's scoring functions could not predict the active compounds. This was due to the limitations in the docking methodology that neglected the receptor flexibility and desolvation parameters. Hence, to recognise the desolvation and explicit solvent effects, as well as to study the Structure-Activity Relationships (SARs) extensively, WaterMap (WM) calculations were performed on the congeneric compounds. Based on displaceable unfavourable hydration sites (HS) and their associated thermodynamic properties, the WM calculations facilitated in understanding the significance of correlation in the folds of activity of highly active (19 and 17), moderately active (16 and 21) and less active (26 and 25) compounds. Furthermore, the scoring function from WaterMap, namely WM/MM, led to a significant R2 value of 0.72 due to a coupled conjunction with MM treatment and displaced unfavourable waters at the binding site. To check the "optimal binding conformation", molecular dynamics simulation was carried out with the highly active compound 19 to explain the binding mode, stability, interactions, solvent-accessible area, etc., which could support the predicted conformation with bioactive conformation.
This study determined the best scoring function, established SARs and predicted active molecules through a computational model. This will contribute to the development of the most potent PAK1 inhibitors.
本研究旨在开发和建立一个能够识别 p21 激活激酶 1(PAK1)有效分子的计算模型。
PAK1 是一个经过充分验证的药物靶点,已经被探索用于各种治疗干预。控制这种蛋白质需要一种不可或缺的抑制剂来抑制结构变化,并随后抑制负责疾病进展的信号效应物的激活,如癌症、炎症、病毒和神经疾病。
该研究旨在建立一个能够识别活性分子的计算模型,这将为开发潜在的 PAK1 抑制剂提供一个平台。
本研究考虑了一组 27 种化合物,其 Ki(nm)覆盖至少 3 个对数范围。这些化合物是基于先前报道的第一组 PAK 抑制剂 G-5555 开发的。对 27 种化合物进行 SP 和 XP 模式对接,以了解结合模式、构象和相互作用模式。为了从计算方法中了解生物活性的相关性,将化合物与生成的水图进行评分,以获得 WM/MM ΔG 结合能。此外,对高活性化合物进行分子动力学分析,以了解复合物的构象可变性和稳定性。然后,我们评估了对接研究中获得的可预测结合构象。
从 SP 和 XP 对接模式中,观察到同系物之间存在与氨基酸残基 Arg299(阳离子-π)、Glu345(芳族氢键)、铰链区 Leu347、盐桥 Asp393 和 Asp407 相互作用的共同相互作用模式。与 PAK1 晶体结构(PDB id: 4EQC)的共晶抑制剂 FRAX597 进行比较。SP 和 XP 模式中的不同对接参数之间的相关性并不显著,这表明 SP 和 XP 的评分函数不能预测活性化合物。这是由于对接方法的局限性,忽略了受体的灵活性和去溶剂化参数。因此,为了识别去溶剂化和显式溶剂效应,并广泛研究结构-活性关系(SARs),对同系物进行了水图(WM)计算。基于可置换不利水合位点(HS)及其相关热力学特性,WM 计算有助于理解高度活跃(19 和 17)、中度活跃(16 和 21)和不活跃(26 和 25)化合物的活性折叠中的相关性的重要性。此外,来自水图的评分函数,即 WM/MM,由于与 MM 处理的耦合结合以及在结合部位置换不利的水,导致显著的 R2 值为 0.72。为了检查“最佳结合构象”,对高活性化合物 19 进行了分子动力学模拟,以解释结合模式、稳定性、相互作用、溶剂可及表面积等,这可以支持具有生物活性构象的预测构象。
本研究通过计算模型确定了最佳评分函数,建立了 SARs,并预测了活性分子。这将有助于开发最有效的 PAK1 抑制剂。